CRN's FTC Enforcement Action Compilation

The purpose of this compilation is to provide information about and access to dietary supplement—and functional food-related enforcement actions issued by the Federal Trade Commission (FTC). CRN publishes this web page as a service to its members and for informational purposes only. It is not intended as a substitute for legal advice, and CRN cannot guarantee the accuracy or completeness of the information provided. Please visit the FTC’s website at www.ftc.gov for additional information about FTC and its enforcement efforts. Please consult professional legal counsel with any specific questions or for legal advice regarding the information published on this website.

Search via the fields provided below or scroll/page through to browse cases. Click here to download compilation as PDF.

Date of Decision:
Company:
XXL Impressions LLC / J2 Response L.L.P. / Synergixx, LLC
Product: CogniPrin and FlexiPrin
Product Category:
  • Cognitive Health
  • Memory
  • Joint Health
Last Action:
$6.57 million judgment (partially suspended) / 20-year ban on direct response marketing of food, dietary supplements, or drugs for which a health benefit is claimed / Banned from making claims related to pain relief, cartilage rebuilding, cognitive decline, memory improvement, and disease unless substantiated by competent and reliable scientific evidence that is sufficient in quality and quantity based on standards accepted by experts in the relevant disease, condition, or function to which the representation relates / Such testing shall be randomized, double-blind, and placebo-controlled and conducted by researchers qualified to conduct such testing / Prohibited from misrepresenting any tests or studies, or that a product is proven to reduce pain, improve memory or cognition or provide other benefits / Prohibited from misrepresenting endorsements / Prohibited from misrepresenting that paid advertising is independent or educational programming, or an objective news report / Additional requirements for clear and conspicuous disclosures regarding advertising and purchase conditions
Additional Information:
Joint action with Maine AG / Preservation of records required, except for reliably reported tests